G01N 33/5058
Neurological cells
Official title: {Neurological cells}
G01N33/5058 (Neurological cells) appears on 798 US grants and 1,457 published applications in this corpus.
Search patents in G01N- Granted patents
- 798
- Published applications
- 1,457
- Assignees
- 657
- Inventors
- 2,654
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 10 | 0 |
| 1999 | 9 | 0 |
| 2000 | 17 | 0 |
| 2001 | 11 | 5 |
| 2002 | 24 | 36 |
| 2003 | 12 | 60 |
| 2004 | 9 | 38 |
| 2005 | 16 | 41 |
| 2006 | 24 | 40 |
| 2007 | 22 | 60 |
| 2008 | 17 | 59 |
| 2009 | 16 | 53 |
| 2010 | 36 | 58 |
| 2011 | 34 | 48 |
| 2012 | 28 | 59 |
| 2013 | 32 | 51 |
| 2014 | 37 | 62 |
| 2015 | 26 | 66 |
| 2016 | 43 | 73 |
| 2017 | 35 | 69 |
| 2018 | 34 | 78 |
| 2019 | 39 | 75 |
| 2020 | 57 | 67 |
| 2021 | 35 | 74 |
| 2022 | 42 | 58 |
| 2023 | 26 | 64 |
| 2024 | 32 | 71 |
| 2025 | 31 | 50 |
| 2026 | 34 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Three-dimensional human neural tissues for CRISPR-mediated perturbation of disease genes15 Sep 2026US 12,736,526 B2Massachusetts Institutes of Technology
- Functional cortical organoids, methods of making, and uses thereof15 Sep 2026US 12,736,527 B2The Regents of the University of California
- Diagnostic methods for neural disorders15 Sep 2026US 12,736,528 B2Quiver Holdings Inc.
- Neurodegenerative and amyotrophic model animal25 Aug 2026US 12,714,076 B2Tokyo Metropolitan Institute of Medical Science
- Efficient, scalable production of human retinal progenitors in vitro1 Oct 2026US 2026/0297514 A1
- Pluripotent stem cell-derived rpe cell, preparation, pharmaceutical composition, reagent, method, and kit1 Oct 2026US 2026/0297515 A1Help Regenerative Medicine Technology (Shenzhen) Co., Ltd.
- Application of a brain organoid model for simulating the damage of environmental pollutants to brain development during embryonic period24 Sep 2026US 2026/0287574 A1Tianjin University
- Potency assay matrix for neuronal cells24 Sep 2026US 2026/0287576 A1Aspen Neuroscience, Inc.
- Model for analyzing inflammation and uses thereof10 Sep 2026US 2026/0266804 A1Technion Research & Development Foundation Limited
Most cited
By later US patents
- Vascularized perfused microtissue/micro-organ arrays324US 6,197,575 B1Massachusetts Institute of Technology · 2001
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- Miniaturized cell array methods and apparatus for cell-based screening303US 6,103,479 ACellomics, Inc. · 2000
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998